secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001753926-22-000875
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VP Clinical and Scientific Affairs Jessy Dorn resigns effective July 15, 2022
-----------------------------------------------------------------------------

- Dr. Jessy Dorn, VP Clinical and Scientific Affairs, resigned effective July 15, 2022.
- She served Second Sight Medical Products since 2006.
- No replacement has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392622000875/0001753926-22-000875-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392622000875/g083057_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-22-000875

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer